An integrated drug discovery unit is reducing the gap between drug development and clinical reality.
Category: biotech/medical – Page 181
The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation
Nelson et al. present a detailed biomolecular study of how the APOE-R136S mutation protects against Alzheimer’s disease (AD) in mice and in patient-derived cells. Lots of data on glial contributions and transcriptomic changes. I see this as an excellent target for gene therapies aiming to combat AD. So do the folks at Lexeo Therapeutics (an exciting company you should check out!)
Nelson et al. report that the APOE-R136S mutation protects against APOE4-promoted Alzheimer’s disease pathologies, including phosphorylated Tau accumulation, neuroinflammation and neurodegeneration, in mouse and human neuron models.
Reach of Palliative Care in Parkinson DiseaseProgress and Gaps After a National Team-Based Implementation Project
This website uses a security service to protect against malicious bots. This page is displayed while the website verifies you are not a bot.
Advancing Surgical Robotics with AI-Driven Simulation and Digital Twin Technology
Imagine a surgeon being able to “step inside” a digital version of a patient’s body — studying organs, tissues, and complex structures, rehearsing procedures, and evaluating possible approaches before performing the actual operation.
The integration of robotic surgical assistants (RSAs) in operating rooms offers substantial advantages for both surgeons and patient outcomes. Currently operated through teleoperation by trained surgeons at a console, these surgical robot platforms provide augmented dexterity that has the potential to streamline surgical workflows and alleviate surgeon workloads. Exploring visual behavior cloning for next-generation surgical assistants could further enhance the capabilities and efficiency of robotic-assisted surgeries.
This post introduces two template frameworks for robotic surgical assistance: Surgical First Interactive Autonomy Assistant (SuFIA) and Surgical First Interactive Autonomy Assistant – Behavior Cloning (SuFIA-BC). SuFIA uses natural language guidance and large language models (LLMs) for high-level planning and control of surgical robots, while SuFIA-BC enhances the dexterity and precision of robotic surgical assistants through behavior cloning (BC) techniques. These frameworks explore the recent advances in both LLMs and BC techniques and tune them to excel to the unique challenges of surgical scenes.
This research aims to accelerate the development of surgical robotic assistants, with the eventual goal of alleviating surgeon fatigue, enhancing patient safety, and democratizing access to high-quality healthcare. SuFIA and SuFIA-BC advance this field by demonstrating their capabilities across various surgical subtasks in simulated and physical settings. Moreover, the photorealistic assets introduced in this work enable the broader research community to explore surgical robotics—a field that has traditionally faced significant barriers to entry due to limited data accessibility, the high costs of expert demonstrations, and the expensive hardware required.
Paralyzed man walks again with help of ‘brain bridge’ implant
In a first of its kind procedure, a man left paralyzed after a spinal cord injury was able to walk again. Doctors implanted what they call a \.
FOXO3: The Longevity Switch Inside Our Cells — Decoding the Master Regulator of Aging, Stress, and Disease
Aging is a universal biological process, yet the reasons why some individuals live significantly longer and healthier lives have long puzzled scientists. Among the genes linked to exceptional longevity, FOXO3 consistently stands out as one of the most influential “master controllers” of cellular resilience. This single transcription factor integrates signals from stress, metabolism, DNA repair, and stem cell biology, orchestrating a vast genetic program that determines how cells survive, adapt, or age [1].
In recent years, interest in FOXO3 has surged across aging research, regenerative medicine, oncology, and precision therapeutics. Variants of the FOXO3 gene are strongly associated with centenarian populations worldwide, while disruptions in its regulatory network contribute to multiple disorders, including cancer, neurodegeneration, metabolic decline, and tissue degeneration. With advances in computational biology and pathway analysis, it is now possible to map FOXO3’s complex signaling network and uncover new therapeutic strategies.
This blog post explores FOXO3’s multifaceted biological roles, its influence on disease, and what our curated data from TRANSFAC®, TRANSPATH®, and HumanPSD™ reveals about the FOXO3 regulatory network. The goal is to provide a scientifically rich yet accessible overview that sparks curiosity among researchers studying aging, longevity, and systems-level biology.
Neuralink competitor Paradromics just implanted its first brain-chip device. Next is restoring speech
Paradromics CEO Matt Angle said the patient will start testing the device in the coming weeks with the goal of restoring her ability to communicate.
Abstract: 1 Department of Neurosurgery, Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
1 Department of Neurosurgery, Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
2Neuro-Microscopy and Minimally Invasive Translational Medicine Innovation Center, Affiliated Hospital of Nantong University, Nantong, China.
3Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China.
T cell control of the intestinal barrier and gut microbiota during ageing
The epithelial, microbial, and immune components of the intestinal barrier coexist in harmony to prevent undesirable inflammatory outcomes and ensure homeostasis in the host. In this review, we outline molecular mechanisms by which T cells regulate intestinal homeostasis and how the ageing-associated dysfunction of T cells could disturb host–microbiota symbiosis and the physical integrity of the intestinal barrier, ultimately driving inflammageing and poor health outcomes. Finally, we propose microbiota- and T cell-based therapeutic interventions aimed at strengthening the intestinal barrier to promote healthier longevity. Namely, we discuss the transplantation of youthful microbiota, the use of designed probiotics, and the adoptive transfer of competent or engineered T cells.
Abstract: Address correspondence to: Douglas E
Vaughan, Northwestern University Feinberg School of Medicine, Simpson Querrey Biomedical Research Center 8–516303 E. Superior St., Chicago, Illinois 60,611, USA. Phone: 312.503.1531; Email: [email protected].







